|
|
|
|
|
|
|
||
J. Exp. Med.,
Volume 188, Number 10, November 16, 1998 1941-1953
By
From the * Laboratory of Parasitic Diseases and the We have developed a model of cutaneous leishmaniasis due to Leishmania major that seeks to
mimic the natural conditions of infection. 1,000 metacyclic promastigotes were coinoculated
with a salivary gland sonicate (SGS) obtained from a natural vector, Phlebotomus papatasii, into
the ear dermis of naive mice or of mice preexposed to SGS. The studies reveal a dramatic exacerbating effect of SGS on lesion development in the dermal site, and a complete abrogation of
this effect in mice preexposed to salivary components. In both BALB/c and C57Bl/6 (B/6)
mice, the dermal lesions appeared earlier, were more destructive, and contained greater numbers of parasites after infection in the presence of SGS. Furthermore, coinoculation of SGS
converted B/6 mice into a nonhealing phenotype. No effect of SGS was seen in either IL-4- deficient or in SCID mice. Disease exacerbation in both BALB/c and B/6 mice was associated
with an early (6 h) increase in the frequency of epidermal cells producing type 2 cytokines.
SGS did not elicit type 2 cytokines in the epidermis of mice previously injected with SGS.
These mice made antisaliva antibodies that were able to neutralize the ability of SGS to enhance infection and to elicit IL-4 and IL-5 responses in the epidermis. These results are the first
to suggest that for individuals at risk of vector-borne infections, history of exposure to vector
saliva might influence the outcome of exposure to transmitted parasites.
Laboratory of Immunology, National Institute of
Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892; and the § Department of Entomology, Walter Reed Army Institute of Research, Washington DC 20307
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
| TABLE OF CONTENTS |
|
